Tilak Baba

Transplant Hepatology Fellow. Georgetown University Hospital, Washington DC. Professional GI/Hep, Amateur photographer, traveler & Expert #TarheelForLife.

[Tilak Baba @TilakBabaMD]

@AtoosaRabiee @AGA_Gastro Thanks for sharing! Since we don’t have bezafibrate here in US should we apply this towards fenofibrate 🤔

[Liver Transplantation Journal (LTxJournal) @LTxJournal]

#Livertwitter tweetorial featuring @AsraniSumeet, @serperm, @nadimmahmud, @DrLiver, and more!

First, do you use lactate to predict prognosis in hospitalized patients with cirrhosis?

[Tilak Baba @TilakBabaMD]

@LizzieAbyMD @VaNiPaLeTi @stevenbollipo @GutGirlMD @AtoosaRabiee @KapuriaMd @DeepikaDevuniMD @ebtapper @CLD_Learning This is excellent. Thanks!

[United Network for Organ Sharing (UNOS) @UNOSNews]

“If you were to compare year-over-year, we have done over 600 more #transplants this time in 2020 compared to last year 2019.” - Dr. Matthew Cooper @MedStarGUH #SavingLivesTogether #TransplantTwitter #OPOs

[Tilak Baba @TilakBabaMD]

@TenzinChodenMD @GeorgetownGI @GAlzayer Thanks everyone!! It was a great experience

[Russell Rosenblatt @rrosenblattmd]

As always, nice study by @AutoImmuneLiver in @JHepatology. The improvement and normalization of alk phos hint at a possible benefit of budesonide. Maybe ↗️ recruitment in US since only OCA offered (not bezafibrate). #livertwitter https://t.co/3D2cQv1ar5

[AASLD @AASLDtweets]

From @HEP_Journal: "Novel Risk Prediction Models for Post‐Operative Mortality in Patients with Cirrhosis" https://t.co/wDvY3zDede #AASLDjournals #LiverTwitter @serperm @gnioannou @nadimmahmud @DrLiver #cirrhosis

[Russell Rosenblatt @rrosenblattmd]

IRBs are incredibly important to protect patient's rights - no doubt. But, when the IRB is so cumbersome, confusing, and frustrating that it requires specialistS and is overworked that it take months for retro reviews, it's time to rethink this. Thoughts?

[Tilak Baba @TilakBabaMD]

Inpatient hepatology service in action! Utilizing best available technology for all encompassing #hepatology care. #livertwitter @AASLDtweets @GeorgetownGI

[Karen S @KStrengerPA]

At MGTI we use #POCUS to improve patient care. Thank you all for making this and many more educational moments possible: @MedStarGUH @GtownPocus @gtown_medres @ButterflyNetInc @bthomas21 @RohitSatoskarMD @TilakBabaMD

[Liver Transplantation Journal (LTxJournal) @LTxJournal]

Frailty in Acute on Chronic Liver Failure (#ACLF) by Shah @DrLiver @VinaySundaramMD et al
▪️Retrospective, 🇺🇸Veterans w/cirrhosis, 2008-2016
▪️Hospital Frailty Risk Score: ICD based
▪️Aim: Evaluate impact of #frailty on odds of ACLF 🏥 & 🪦
https://t.co/FazR50xjAQ
#livertwitter

[#ScopingSundays @ScopingSundays]

Missed the amazing discussion on our previous #ScopingSundays on “Small Bowel Bleeding” lead by @DHassMD, @PerelmansPearls & @annefanliu_md, or not finding the time to go through the thread ?

Check out the #ScopingSummary for high-yield pearls prepared by @NasirSaleemMD

[ACG @AmCollegeGastro]

Join ACG on Thurs 5/28 @ Noon EDT for Virtual #GrandRounds #GIhomeschooling w/ @DrR_Williams on #ColorectalCancer Screening in a Post-COVID World

➡️Register: https://t.co/9t8dHChSZw

#GetYourGILearnOn #ACGfamily #GIcommunity #Gastroenterology #GIFellowship

[Elliot Tapper @ebtapper]

It’s controversy week @JHepatology!

Two 🔥papers, My alt titles

1. Hey, dont give BB to hypotensive patients! https://t.co/bGQDqdLX6O

2. Your patient has liver mass and you aren’t sure if it is cancer? Hold the HCV treatment 4 lil bit. https://t.co/uDPoI28fem

#LiverTwitter

[Elliot Tapper @ebtapper]

Alcoholic hepattitis is more common than ever

Particularly in:

1️⃣age 20-39
2️⃣men>women
3️⃣Caucasian
4️⃣Massachusetts

This is bad

#LiverTwitter
https://t.co/lLL2MSa7m8

[Tilak Baba @TilakBabaMD]

Abdominal wall pain. Great step by step approach in not just diagnosing but treating right then! #CarnettToTheRescue #gitwitter @AmCollegeGastro

[Tilak Baba @TilakBabaMD]

@AtoosaRabiee @docamitgs @nicole_rich8 @renumathyd @jmarrero6713 @AnjanaPillaiMD I would think concordance in two noninvasive markers (eg FIB4/APRI + FibroScan) would convince me to screen if they suggest AF. Otherwise biopsy and then decide?

[Utibe R. Essien, MD MPH @UREssien]

New study in @Health_Affairs with some key findings:

- Blacks were less likely to be tested for #COVID19 as outpatient
- Black were 2x more likely to be hospitalized for Covid-19
- Patients with Medicaid/ uninsured were 2x more likely to be hospitalized

https://t.co/w2mh5RZvOi

[Tilak Baba @TilakBabaMD]

Remember advanced fibrosis = #HCC screening not just #cirrhosis #livertwitter @AmerGastroAssn

[American Gastroenterological Association (AGA) @AmerGastroAssn]

.@AGA_Gastro has released new AGA clinical guidance detailing when clinicians need to screen for hepatocellular carcinoma #HCC in their #NAFLD patients. https://t.co/0EwBg0BFAq

[SECURE-Liver @SecureLiver]

We are pleased to share our interim data from
@CovidHep and @SecureCirrhosis published online in @JHepatology

Thank you to all clinicians who continue to contribute cases to these registries helping us better understand COVID-19 in chronic liver disease

https://t.co/bWMHciWrgS

[Tony Breu @tony_breu]

1/15
Why do patients with liver injury or dysfunction have conjugated hyperbilirubinemia?

If hepatocytes conjugate, why doesn't this "liver function" decrease in settings of severe inflammatory or fibrosis?

Before I offer a fuller explanation, I'll ask you: which plays a role?